Publicaciones (88) Publicaciones en las que ha participado algún/a investigador/a

2006

  1. (AAT)n repeat in the cannabinoid receptor gene, CNR1: Association with schizophrenia in a Spanish population

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 256, Núm. 7, pp. 437-441

  2. 6.2. Alucinógenos, anfetaminas y drogas de síntesis. 6.2.1. Bases biológicas

    Tratado SET de Trastornos Adictivos (Editorial Médica Panamericana), pp. 181-187

  3. 6.4. Cannabis. 6.4.1. Bases biológicas

    Tratado SET de Trastornos Adictivos (Editorial Médica Panamericana), pp. 222-225

  4. A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells

    Molecular Pharmacology, Vol. 70, Núm. 1, pp. 51-59

  5. A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme

    British Journal of Cancer, Vol. 95, Núm. 2, pp. 197-203

  6. A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke

    Journal of Experimental Medicine, Vol. 203, Núm. 3, pp. 711-717

  7. ATP from subplasmalemmal mitochondria controls Ca2+-dependent inactivation of CRAC channels

    Journal of Biological Chemistry, Vol. 281, Núm. 47, pp. 35616-35623

  8. Activation pathways of α4β1 integrin leading to distinct T-cell cytoskeleton reorganization, Rac1 regulation and Pyk2 phosphorylation

    Journal of Cellular Physiology, Vol. 207, Núm. 3, pp. 746-756

  9. Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations

    Journal of Neurochemistry, Vol. 99, Núm. 2, pp. 677-688

  10. An overview of Parkinson's disease and the cannabinoid system and possible benefits of cannabinoid-based treatments

    Current Medicinal Chemistry, Vol. 13, Núm. 30, pp. 3705-3718

  11. Backbone dynamics of a biologically active human FGF-1 monomer, complexed to a hexasaccharide heparin-analogue, by 15N NMR relaxation methods

    Journal of Biomolecular NMR, Vol. 35, Núm. 4, pp. 225-239

  12. Beta-amyloid-dependent expression of NOS2 in neurons: Prevention by an α2-adrenergic antagonist

    Antioxidants and Redox Signaling, Vol. 8, Núm. 5-6, pp. 873-883

  13. Búsqueda de un tratamiento farmacológico para la dependencia de la marihuana

    Adicciones: Revista de socidrogalcohol, Vol. 18, Núm. 1, pp. 5-9

  14. Cadmium induces reactive oxygen species generation and lipid peroxidation in cortical neurons in culture

    Free Radical Biology and Medicine, Vol. 40, Núm. 6, pp. 940-951

  15. Cannabinoid receptors as novel targets for the treatment of melanoma

    FASEB Journal, Vol. 20, Núm. 14

  16. Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes

    Cancer Research, Vol. 66, Núm. 13, pp. 6748-6755

  17. Changes in CB1 receptors in motor-related brain structures of chronic relapsing experimental allergic encephalomyelitis mice

    Brain Research, Vol. 1107, Núm. 1, pp. 199-205

  18. Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats

    Pediatric Research, Vol. 60, Núm. 2, pp. 169-173

  19. Chronic Δ9-tetrahydrocannabinol administration affects serotonin levels in the rat frontal cortex

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 372, Núm. 4, pp. 313-317

  20. Conformational insights on the molecular recognition processes of carbohydrate molecules by proteins and enzymes: A 3D view by using NMR

    Biocatalysis and Biotransformation, Vol. 24, Núm. 1-2, pp. 13-22